Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -12.94-38.8556.85-117.9142.03

What is the latest Core EBITDA Growth ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest Core EBITDA Growth ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is -12.94 based on Mar2023 Standalone results.
Year Core EBITDA Growth
Mar2023-12.94
Mar2022-38.85
Mar202156.85
Mar2020-117.91
Mar201942.03

How is Core EBITDA Growth of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years Core EBITDA Growth % Change
Mar2023 -12.94
Negative
Mar2022 -38.85
Negative
Mar2021 56.85
Positive
Mar2020 -117.91
Negative
Mar2019 42.03 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare Core EBITDA Growth ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹7,093.6 Cr -0.3% -43.8% 11.4% Stock Analytics
SYNGENE INTERNATIONAL ₹27,801.2 Cr 2.4% -2.7% -1.8% Stock Analytics
LATENT VIEW ANALYTICS ₹9,934.2 Cr 5.2% -8.6% 40.9% Stock Analytics
JUST DIAL ₹8,285.1 Cr -3.1% 9% 40.8% Stock Analytics
DREAMFOLKS SERVICES ₹2,737.7 Cr 2.1% -0.1% 3.5% Stock Analytics
EKI ENERGY SERVICES ₹902.2 Cr -1% -0.1% -25% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-0.3%

-43.8%

11.4%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses